Soleus Capital Management, L.P. Edgewise Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.41 - $22.41 $451,033 - $701,433	-31,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$21.33 - $30.25 $1.47 Million - $2.08 Million	-68,700 Reduced 68.7%	31,300 $668,000
Q1 2021 May 17, 2021	BUY	$30.0 - $35.99 $3 Million - $3.6 Million	100,000 New	100,000 $3.25 Million

191

100M

2.17M

410K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $2.02B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.